Overview

Topical Timolol for the Treatment of Benign Vascular Periocular Lesions

Status:
Withdrawn
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to find out if the use of topical timolol 0.5% solution applied twice daily will help to shrink rosacea lesions around the eye.
Phase:
Phase 4
Details
Lead Sponsor:
Loyola University
Treatments:
Timolol